Singapore biotech start-up Mirxes launches IPO in Hong Kong to raise $181 million

Mirxes co-founder and chief executive Zhou Lihan. The biotech start-up focuses on microRNA-based cancer detection.PHOTO: MIRXES SINGAPORE - Singapore biotech firm Mirxes launched its initial public offering (IPO) in Hong Kong on May 15, aiming to raise HK$ …

Hong Kong: Insurer launches digital wellness plan

Chubb Life Hong Kong has launched a digital insurance plan aimed at promoting and facilitating well-being practices for individuals wishing to achieve a healthier lifestyle. The Health Up plan is designed to offer term life coverage and accidental death …

Uma Nota and Bedu to shut down in Hong Kong this summer

Staying afloat in Hong Kong’s food and drink scene is no easy feat. With steep rent prices, consumers travelling to Mainland China for affordable spending, and fierce competition between competitors, many local restaurants are bearing the brunt of high …

Hong Kong Securities and Futures Commission And UAE ADGM’s Financial Services Regulatory Authority Enhances Regulatory ...

The Securities and Futures Commission (SFC) and the Financial Services Regulatory Authority (FSRA) of ADGM (Note 1) have entered into a Memorandum of Understanding (MoU) to enhance cooperation on supervision of investment managers of collective investment …

May Chow and Joya share how they’re preparing for motherhood and navigating the idea of queer parenthood in Hong Kong

It’s just meat and potatoes—but sometimes, that’s enough to move you. It’s not a chicken hurriedly crisped in an air fryer, nor a perfectly sliced sliver of Wagyu on a tasting menu plate. This is meat left to blister, be basted and rest. Potatoes burnished …

Hengrui, one of China's leading biotechs, anticipates $1.2B in proposed Hong Kong listing

Mirxes to raise $112.7m in Hong Kong IPO

Hong Kong is solid plan B for robotaxi operator

Just 6 months after its New York IPO, China's Pony AI may be exploring a listing in the city. The risk of being kicked off American exchanges makes finding a second home more urgent. Meanwhile, dual-listed Alibaba and peers show the Asian financial hub …

COVID-19 spikes in Hong Kong, Singapore as new wave spreads

China’s Jiangsu Hengrui Pharmaceuticals aims to raise up to $1.27b in Hong Kong IPO

Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a regulatory filing made on Thursday. The offer price will be between HK$41. …